IMC Chicago
PACB icon

IMC Chicago’s Pacific Biosciences PACB Stock Holding History

IMC Chicago’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Sell
160,900
-103,200
-39% -$185K ﹤0.01% 4952
2025
Q4 		$494K Buy
+264,100
New +$507K ﹤0.01% 3490
2024
Q2 		– Sell
-110,200
Closed -$413K – 2739
2024
Q1 		$413K Buy
+110,200
New +$645K ﹤0.01% 2134

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IMC Chicago's PACB Position: Q2 2024 in Review

IMC Chicago sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 115,620 shares — an estimated $434K sold.

IMC Chicago first reported a position in PACB in Q1 2024 and held it in 1 quarter. The position peaked at $434K in Q1 2024. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • IMC Chicago reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • IMC Chicago sold 115,620 Pacific Biosciences shares in Q2 2024, an estimated $434K.
  • IMC Chicago first reported a position in Pacific Biosciences in Q1 2024 and held it in 1 quarter.
  • IMC Chicago's Pacific Biosciences position peaked at $434K in Q1 2024.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on IMC Chicago's 13F filing for Q2 2024, filed 15 Jul 2024.